Pipazethate

DB08796InvestigationalSmall molecule

A non-narcotic oral antitussive agent.

Chemical structure of Pipazethate
Primary indication
For the treatment of cough.Curator reviewed
Formula / weight
C21H25N3O3S · 399.507 g/mol (avg)
Also known as
Pipazetate
Code names
D-254 · SK&F 70230-A · SQ 15,874

Resolves to

Compound
UNIIM5EK1T5V2LCAS2167-85-3ChEMBLCHEMBL2104900ChEBI135635PubChem22425KEGGD05484
Clinical / RWD
RxNorm33740ATCR05DB11PharmGKBPA165958415
Structure
InChIKeyDTVJXCOMJLLMAK-UHFFFAOYSA-NSMILESO=C(OCCOCCN1CCCCC1)N1C2=CC=CC=C2SC2=C1N=CC=C2

What you can answer from here — as of March 06, 2025

5Marketed productsAcross 2 countries and 2 labellers
Sign in
1ATC codeIncluding every combination product, plus 7 drug categories
Sign in

Which companies are running trials of Pipazethate, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In